featured
Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial
JAMA 2021 Oct 05;326(13)1268-1276, HJ van Esch, L van Zuylen, ECT Geijteman, E Oomen-de Hoop, BAA Huisman, HS Noordzij-Nooteboom, R Boogaard, A van der Heide, CCD van der RijtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.